OppenheimerFunds Inc. raised its stake in Sabra Health Care REIT Inc (NASDAQ:SBRA) by 77.0% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 30,155 shares of the real estate investment trust’s stock after buying an additional 13,121 shares during the quarter. OppenheimerFunds Inc.’s holdings in Sabra Health Care REIT were worth $566,000 at the end of the most recent reporting period.

A number of other institutional investors also recently added to or reduced their stakes in SBRA. Bank of New York Mellon Corp increased its stake in shares of Sabra Health Care REIT by 294.2% during the 3rd quarter. Bank of New York Mellon Corp now owns 4,721,303 shares of the real estate investment trust’s stock worth $103,586,000 after purchasing an additional 3,523,631 shares during the last quarter. BlackRock Inc. increased its stake in shares of Sabra Health Care REIT by 7.0% during the 4th quarter. BlackRock Inc. now owns 25,569,768 shares of the real estate investment trust’s stock worth $479,945,000 after purchasing an additional 1,673,758 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in shares of Sabra Health Care REIT by 151.8% during the 3rd quarter. Dimensional Fund Advisors LP now owns 2,405,450 shares of the real estate investment trust’s stock worth $52,774,000 after purchasing an additional 1,450,287 shares during the last quarter. JPMorgan Chase & Co. increased its stake in shares of Sabra Health Care REIT by 5,107.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 893,243 shares of the real estate investment trust’s stock worth $19,348,000 after purchasing an additional 876,089 shares during the last quarter. Finally, Ameriprise Financial Inc. increased its stake in shares of Sabra Health Care REIT by 115.1% during the 3rd quarter. Ameriprise Financial Inc. now owns 1,326,601 shares of the real estate investment trust’s stock worth $29,105,000 after purchasing an additional 709,983 shares during the last quarter. Hedge funds and other institutional investors own 88.88% of the company’s stock.

How to Become a New Pot Stock Millionaire

Sabra Health Care REIT stock opened at $17.41 on Thursday. Sabra Health Care REIT Inc has a 12 month low of $15.77 and a 12 month high of $29.10. The company has a quick ratio of 6.85, a current ratio of 6.85 and a debt-to-equity ratio of 0.99. The stock has a market cap of $3,124.82, a price-to-earnings ratio of 7.56, a P/E/G ratio of 2.37 and a beta of 0.75.

Sabra Health Care REIT (NASDAQ:SBRA) last issued its quarterly earnings results on Wednesday, February 21st. The real estate investment trust reported $0.57 earnings per share for the quarter, beating analysts’ consensus estimates of $0.30 by $0.27. Sabra Health Care REIT had a net margin of 39.04% and a return on equity of 7.19%. The firm had revenue of $166.47 million during the quarter, compared to the consensus estimate of $158.82 million. equities analysts anticipate that Sabra Health Care REIT Inc will post 2.5 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Wednesday, February 28th. Shareholders of record on Thursday, February 15th were issued a $0.45 dividend. This represents a $1.80 dividend on an annualized basis and a yield of 10.34%. The ex-dividend date of this dividend was Wednesday, February 14th. Sabra Health Care REIT’s dividend payout ratio (DPR) is presently 150.00%.

Several research analysts have recently commented on the stock. Wells Fargo dropped their price target on shares of Sabra Health Care REIT from $24.00 to $19.00 and set a “market perform” rating on the stock in a research note on Tuesday. They noted that the move was a valuation call. Mizuho upgraded shares of Sabra Health Care REIT from a “neutral” rating to a “buy” rating and set a $24.00 target price on the stock in a research note on Wednesday, March 14th. BidaskClub upgraded shares of Sabra Health Care REIT from a “strong sell” rating to a “sell” rating in a research note on Thursday, March 8th. Zacks Investment Research lowered shares of Sabra Health Care REIT from a “hold” rating to a “sell” rating in a research note on Tuesday, February 27th. Finally, Stifel Nicolaus reiterated a “hold” rating and issued a $21.00 target price (down from $22.00) on shares of Sabra Health Care REIT in a research note on Thursday, February 22nd. Three analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $23.64.

ILLEGAL ACTIVITY NOTICE: “OppenheimerFunds Inc. Grows Holdings in Sabra Health Care REIT Inc (SBRA)” was published by Watch List News and is the property of of Watch List News. If you are reading this piece on another publication, it was copied illegally and republished in violation of U.S. & international trademark and copyright legislation. The legal version of this piece can be viewed at https://www.watchlistnews.com/oppenheimerfunds-inc-grows-holdings-in-sabra-health-care-reit-inc-sbra/1956450.html.

Sabra Health Care REIT Company Profile

Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.

Institutional Ownership by Quarter for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.